Aisling Capital IV LP 13D and 13G filings for Viracta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 12:14 pm Purchase | 2021-12-31 | 13G | Viracta Therapeutics, Inc. VIRX | Aisling Capital IV LP | 288,571 0.770% | 288,571 (New Position) | Filing |